Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 02:23:12 2024-07-12 pm EDT			5-day change	1st Jan Change
104.6 ^USD	+0.45%		+0.53%	-5.00%

Jul. 10	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $118 From $121	MT
Jul. 10	DexCom, Inc. : A Must-Have Tool for Diabetes Care

Abbott Labs: 15% growth in quarterly EPS

January 24, 2024 at 08:47 am EST

Abbott Laboratories reports fourth-quarter 2023 adjusted EPS of $1.19, up 15.5% year-on-year, on revenues up 1.5% to $10.2 billion.

On an organic basis and excluding sales linked to Covid-19 tests, the healthcare group's quarterly sales rose by 11%, boosted in particular by the medical devices (+15.4%) and nutrition (+13.9%) divisions.

With full-year 2023 adjusted EPS of $4.44 and organic sales growth (excluding Covid-19-related revenues) of 11.6%, Abbott expects 2024 target ranges of $4.50-4.70 and 8-10% respectively.

Copyright (c) 2024 CercleFinance.com. All rights reserved.

Go to the original article.
Legal disclaimer

Latest news about Abbott Laboratories

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $118 From $121	Jul. 10	MT
DexCom, Inc. : A Must-Have Tool for Diabetes Care	Jul. 10
That's not so bad, is it?	Jul. 08
Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating	Jul. 02	MT
Abbott Laboratories(NYSE:ABT) dropped from Russell Top 200 Growth Index	Jun. 30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 3000 Growth Index	Jun. 30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 3000E Growth Index	Jun. 30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 1000 Growth Index	Jun. 30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 1000 Growth-Defensive Index	Jun. 30	CI
Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health	Jun. 20	CI
Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15	Jun. 14	MT
Abbott Laboratories Declares Quarterly Common Dividend, Payable on August 15, 2024	Jun. 14	CI
Abbott Laboratories Says US FDA Approved 2 Over-The-Counter Continuous Glucose Monitoring Wearable Systems	Jun. 10	MT
US FDA clears Abbott's continuous glucose monitors for over-the-counter use	Jun. 10	RE
Abbott Receives U.S. FDA Clearance for Two New Over-The-Counter Continuous Glucose Monitoring Systems	Jun. 10	CI
U.S. FDA set to reorganize its food division starting October	May. 30	RE
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115	May. 30	MT
Medtronic beats quarterly profit estimates on medical devices strength	May. 23	RE
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating	May. 22	MT
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit	May. 15	MT
Drugmaker Abbott India posts Q4 profit rise on higher sales	May. 09	RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing	May. 08	MT
Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on December 10, 2021.	May. 02	CI
Abbott Laboratories Announces Retirement of Robert E. Funck, Jr as Executive Vice President, Finance, Effective July 1, 2024	May. 01	CI
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee	Apr. 29	MT

Chart Abbott Laboratories

Duration

Period

More charts

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-14 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Abbott Laboratories

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

104.2 USD

Average target price

124.8 USD

Spread / Average Target

+19.77%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-5.00%	181B
MEDTRONIC PLC	-5.09%	100B
BECTON, DICKINSON AND COMPANY	-5.72%	65.01B
HOYA CORPORATION	+16.45%	45.75B
DEXCOM, INC.	-7.58%	44.8B
CENCORA, INC.	+8.64%	43.72B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.72%	29.01B
TERUMO CORPORATION	+17.98%	26.03B
WEST PHARMACEUTICAL SERVICES, INC.	-7.09%	24.28B
ZIMMER BIOMET HOLDINGS, INC.	-10.31%	22.26B

Other Medical Equipment, Supplies & Distribution